This inventor holds 2 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: The Innovations of Stephan Hilger
Introduction
Stephan Hilger is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medical technology, particularly in the development of innovative chelating agents and therapeutic processes. With a total of 2 patents, his work has the potential to impact radiodiagnosis and radiotherapy significantly.
Latest Patents
Hilger's latest patents include "Chelating agents as well as their tricarbonyl complexes with technetium and rhenium." This invention describes new chelating agents and their complexes, which are utilized in radiodiagnosis and radiotherapy. The new agents are designed to couple with substances that accumulate in diseased tissue, enhancing the effectiveness of treatment. Another patent focuses on a "Process for therapeutic treatment of proliferative diseases." This process involves placing an administration catheter at the lesion site, administering a radioactive substance topically, and then removing the catheter while the radioactive substance remains at the lesion.
Career Highlights
Stephan Hilger has been associated with Schering Aktiengesellschaft, a company known for its advancements in pharmaceuticals and medical technology. His work at Schering has allowed him to explore innovative solutions for complex medical challenges.
Collaborations
Throughout his career, Hilger has collaborated with esteemed colleagues such as Ludger Dinkelborg and Dieter Heldmann. These collaborations have fostered an environment of innovation and have contributed to the success of his projects.
Conclusion
Stephan Hilger's contributions to the field of medical technology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic treatments and diagnostic methods.